{
  "id": 1523,
  "text": "A recently reported RCT1484 comparing brachytherapy versus brachytherapy and hyperthermia following priori chemoradiotherapy in patients with stage II-III cervical cancer failed to demonstrate any therapeutic benefit in terms of DFS or local control with the addition of hyperthermia.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A recently reported RCT1484 comparing brachytherapy versus brachytherapy and hyperthermia following priori chemoradiotherapy in patients with stage II-III cervical cancer failed to demonstrate any therapeutic benefit in terms of DFS or local control with the addition of hyperthermia.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据当前研究结果，对于II到III期宫颈癌患者，在化疗和放射治疗之后结合温热疗法并未显示在无疾病生存率（DFS）或局部控制效果方面具有显著的治疗优势。因此，目前的证据不支持将温热疗法作为标准治疗的一部分用于这一患者群体。",
  "query": "在进行化疗和放射治疗后，对于II到III期宫颈癌患者，加入温热疗法是否能提高无疾病生存率和局部控制效果？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在进行化疗和放射治疗后，对于II到III期宫颈癌患者，加入温热疗法是否能提高无疾病生存率和局部控制效果？\n\n<reference text>: A recently reported RCT1484 comparing brachytherapy versus brachytherapy and hyperthermia following priori chemoradiotherapy in patients with stage II-III cervical cancer failed to demonstrate any therapeutic benefit in terms of DFS or local control with the addition of hyperthermia.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据当前研究结果，对于II到III期宫颈癌患者，在化疗和放射治疗之后结合温热疗法并未显示在无疾病生存率（DFS）或局部控制效果方面具有显著的治疗优势。因此，目前的证据不支持将温热疗法作为标准治疗的一部分用于这一患者群体。"
}